Patents by Inventor Sachie Nakatani

Sachie Nakatani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OSTEOCLAST DIFFERENTIATION INHIBITOR CONTAINING UROLITHIN
    Publication number: 20200397747
    Abstract: An object of the present invention is to provide an effective and highly safe agent for inhibiting osteoclast differentiation, and a food or drink, pharmaceutical, supplement, and cosmetic that produce an osteoclast differentiation-inhibiting effect; and the object is fulfilled by an agent for inhibiting osteoclast differentiation, comprising a urolithin.
    Type: Application
    Filed: January 29, 2019
    Publication date: December 24, 2020
    Inventors: Kenji KOBATA, Sachie NAKATANI, Masatake KUDOH
  • Collagen peptide, dipeptide and malady inhibitor
    Patent number: 8410062
    Abstract: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: April 2, 2013
    Assignee: Nitta Gelatin Inc.
    Inventors: Fumihito Sugihara, Naoki Inoue, Seiko Koizumi, Chinfang Liu, Hajime Takasaki, Hisayuki Kobayashi, Hiroshi Mano, Sachie Nakatani, Masahiro Wada
  • Collagen peptide, dipeptide and malady inhibitor
    Publication number: 20120258919
    Abstract: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 11, 2012
    Applicant: NITTA GELATIN INC.
    Inventors: Fumihito SUGIHARA, Naoki INOUE, Seiko KOIZUMI, Chinfang LIU, Hajime TAKASAKI, Hisayuki KOBAYASHI, Hiroshi MANO, Sachie NAKATANI, Masahiro WADA
  • Collagen peptide, dipeptide and malady inhibitor
    Patent number: 8227424
    Abstract: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: July 24, 2012
    Assignee: Nitta Gelatin Inc.
    Inventors: Fumihito Sugihara, Naoki Inoue, Seiko Koizumi, Chinfang Liu, Hajime Takasaki, Hisayuki Kobayashi, Hiroshi Mano, Sachie Nakatani, Masahiro Wada
  • Collagen peptide, dipeptide and malady inhibitor
    Publication number: 20110166365
    Abstract: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.
    Type: Application
    Filed: November 14, 2008
    Publication date: July 7, 2011
    Applicant: NITTA GELATIN INC.
    Inventors: Fumihito Sugihara, Naoki Inoue, Seiko Koizumi, Chinfang Liu, Hajime Takasaki, Hisayuki Kobayashi, Hiroshi Mano, Sachie Nakatani, Masahiro Wada